News

News-Medical.Net3h
Long-term survival achieved in stage III melanoma with pre-surgery immunotherapy
Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87 ...
The Manila Times12h
KIF18A Targeting Therapies FDA EMA Approval Clinical Trials By Indication Company Country Drug Class Report
Kuick Research Report highlights ongoing Clinical Development Technology platforms In Recent Research Study On KIF18A ...
News-Medical.Net17h
Teclistamab shows promising results in heavily pretreated multiple myeloma
Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who ...